
Valerie Rodriguez-garcia
Examiner (ID: 10379, Phone: (571)270-5865 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1622, 1626, 1759 |
| Total Applications | 1115 |
| Issued Applications | 735 |
| Pending Applications | 95 |
| Abandoned Applications | 322 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16628609
[patent_doc_number] => 20210047262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => 2-(3,4-DIHYDROXYPHENYL)ETHYL 3-HYDROXYBUTANOATE, COMPOSITION, AND METHOD FOR IMPROVING FUNCTION OF AORTIC ENDOTHELIAL CELL
[patent_app_type] => utility
[patent_app_number] => 16/583263
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16583263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/583263 | 2-(3,4-dihydroxyphenyl)ethyl 3-hydroxybutanoate, composition, and method for improving function of aortic endothelial cell | Sep 25, 2019 | Issued |
Array
(
[id] => 15589489
[patent_doc_number] => 20200071279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/560478
[patent_app_country] => US
[patent_app_date] => 2019-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16560478
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/560478 | DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF | Sep 3, 2019 | Abandoned |
Array
(
[id] => 17052080
[patent_doc_number] => 20210261514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => Method for Preparation of 1,4-Sorbitan
[patent_app_type] => utility
[patent_app_number] => 17/265939
[patent_app_country] => US
[patent_app_date] => 2019-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265939 | Method for preparation of 1,4-sorbitan | Aug 25, 2019 | Issued |
Array
(
[id] => 16681684
[patent_doc_number] => 10941150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 16/548303
[patent_app_country] => US
[patent_app_date] => 2019-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 6402
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16548303
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/548303 | Salt type and crystal type of 4h-pyrazolo [1, 5-alpha] benzimidazole compound and preparation method and intermediate thereof | Aug 21, 2019 | Issued |
Array
(
[id] => 17074830
[patent_doc_number] => 11111214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-07
[patent_title] => Kappa opioid agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/529504
[patent_app_country] => US
[patent_app_date] => 2019-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48505
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16529504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/529504 | Kappa opioid agonists and uses thereof | Jul 31, 2019 | Issued |
Array
(
[id] => 16741986
[patent_doc_number] => 10966952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 16/525319
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 3752
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525319
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525319 | Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions | Jul 28, 2019 | Issued |
Array
(
[id] => 18932235
[patent_doc_number] => 11884641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Method for decomposing flavonoid glycoside and method for producing flavonoid
[patent_app_type] => utility
[patent_app_number] => 17/263141
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5589
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17263141
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/263141 | Method for decomposing flavonoid glycoside and method for producing flavonoid | Jul 25, 2019 | Issued |
Array
(
[id] => 17178310
[patent_doc_number] => 11155544
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Heterocycle comprising tyrosine kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/523979
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27754
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16523979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/523979 | Heterocycle comprising tyrosine kinase inhibitors | Jul 25, 2019 | Issued |
Array
(
[id] => 17111697
[patent_doc_number] => 20210292294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD FOR DECOMPOSING FLAVONOID GLYCOSIDE AND METHOD FOR PRODUCING FLAVONOID
[patent_app_type] => utility
[patent_app_number] => 17/262207
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262207 | Method for decomposing flavonoid glycoside and method for producing flavonoid | Jul 25, 2019 | Issued |
Array
(
[id] => 15083405
[patent_doc_number] => 20190336513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => THROMBOXANE RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/517947
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16517947
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/517947 | Thromboxane receptor antagonists | Jul 21, 2019 | Issued |
Array
(
[id] => 15527833
[patent_doc_number] => 20200056222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Flash and Glow 1,2-Dioxetanes
[patent_app_type] => utility
[patent_app_number] => 16/510531
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510531
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510531 | Flash and Glow 1,2-Dioxetanes | Jul 11, 2019 | Abandoned |
Array
(
[id] => 15323933
[patent_doc_number] => 20200002296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => TRIAZOLE DERIVATIVES AND THEIR USE AS PDE4 ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 16/508001
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16508001
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/508001 | Triazole derivatives and their use as PDE4 activators | Jul 9, 2019 | Issued |
Array
(
[id] => 15993327
[patent_doc_number] => 20200172534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/460381
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16460381
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/460381 | Compounds and compositions for treating conditions associated with STING activity | Jul 1, 2019 | Issued |
Array
(
[id] => 19909068
[patent_doc_number] => 12285250
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Near-IR glucose sensors
[patent_app_type] => utility
[patent_app_number] => 16/455038
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 49684
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/455038 | Near-IR glucose sensors | Jun 26, 2019 | Issued |
Array
(
[id] => 17111707
[patent_doc_number] => 20210292304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => DEUTERATED MGL-3196 COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/255231
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255231 | DEUTERATED MGL-3196 COMPOUND AND USE THEREOF | Jun 20, 2019 | Pending |
Array
(
[id] => 16564184
[patent_doc_number] => 10889542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Process for preparing electron deficient olefins
[patent_app_type] => utility
[patent_app_number] => 16/438517
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4913
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438517 | Process for preparing electron deficient olefins | Jun 11, 2019 | Issued |
Array
(
[id] => 14993595
[patent_doc_number] => 20190315755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/432469
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16432469
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/432469 | Bicyclic heterocyclic derivatives as MNK1 and MNK2 modulators and uses thereof | Jun 4, 2019 | Issued |
Array
(
[id] => 15345203
[patent_doc_number] => 20200010493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL] PYRIMIDINE-2,4-DIAMINE
[patent_app_type] => utility
[patent_app_number] => 16/429988
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40550
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429988
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429988 | Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamine | Jun 2, 2019 | Issued |
Array
(
[id] => 16963267
[patent_doc_number] => 20210214766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => DIOXETANE COMPOUNDS AND THEIR USE FOR THE DETECTION OF MICROORGANISMS
[patent_app_type] => utility
[patent_app_number] => 17/058623
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26509
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058623
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058623 | Dioxetane compounds and their use for the detection of microorganisms | May 23, 2019 | Issued |
Array
(
[id] => 15086261
[patent_doc_number] => 20190337941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => TYK2 INHIBITORS, USES, AND METHODS FOR PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/417901
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25642
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16417901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/417901 | TYK2 inhibitors, uses, and methods for production thereof | May 20, 2019 | Issued |